The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Veterinary Anesthesia Drug Market Research Report 2025
Synopsis
Global Veterinary Anesthesia Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Anesthesia Drug market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Anesthesia Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Dechra
LGC Group
AuroMedics
Evonik
Gedeon Richter
Midas Pharma
Fresenius Kabi AG
AstraZeneca
Segment by Type
Ketamine
Propofol
Thiopental
Others
Segment by Application
Pet
Agricultural Livestock
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Veterinary Anesthesia Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Global Veterinary Anesthesia Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Veterinary Anesthesia Drug market research.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Veterinary Anesthesia Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Dechra
LGC Group
AuroMedics
Evonik
Gedeon Richter
Midas Pharma
Fresenius Kabi AG
AstraZeneca
Segment by Type
Ketamine
Propofol
Thiopental
Others
Segment by Application
Pet
Agricultural Livestock
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Veterinary Anesthesia Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Veterinary Anesthesia Drug Market Overview
1.1 Product Overview and Scope of Veterinary Anesthesia Drug
1.2 Veterinary Anesthesia Drug Segment by Type
1.2.1 Global Veterinary Anesthesia Drug Market Value Comparison by Type (2023-2029)
1.2.2 Ketamine
1.2.3 Propofol
1.2.4 Thiopental
1.2.5 Others
1.3 Veterinary Anesthesia Drug Segment by Application
1.3.1 Global Veterinary Anesthesia Drug Market Value by Application: (2023-2029)
1.3.2 Pet
1.3.3 Agricultural Livestock
1.3.4 Others
1.4 Global Veterinary Anesthesia Drug Market Size Estimates and Forecasts
1.4.1 Global Veterinary Anesthesia Drug Revenue 2018-2029
1.4.2 Global Veterinary Anesthesia Drug Sales 2018-2029
1.4.3 Global Veterinary Anesthesia Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Veterinary Anesthesia Drug Market Competition by Manufacturers
2.1 Global Veterinary Anesthesia Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Veterinary Anesthesia Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Veterinary Anesthesia Drug Average Price by Manufacturers (2018-2023)
2.4 Global Veterinary Anesthesia Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Veterinary Anesthesia Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Anesthesia Drug, Product Type & Application
2.7 Veterinary Anesthesia Drug Market Competitive Situation and Trends
2.7.1 Veterinary Anesthesia Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Anesthesia Drug Players Market Share by Revenue
2.7.3 Global Veterinary Anesthesia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Anesthesia Drug Retrospective Market Scenario by Region
3.1 Global Veterinary Anesthesia Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Veterinary Anesthesia Drug Global Veterinary Anesthesia Drug Sales by Region: 2018-2029
3.2.1 Global Veterinary Anesthesia Drug Sales by Region: 2018-2023
3.2.2 Global Veterinary Anesthesia Drug Sales by Region: 2024-2029
3.3 Global Veterinary Anesthesia Drug Global Veterinary Anesthesia Drug Revenue by Region: 2018-2029
3.3.1 Global Veterinary Anesthesia Drug Revenue by Region: 2018-2023
3.3.2 Global Veterinary Anesthesia Drug Revenue by Region: 2024-2029
3.4 North America Veterinary Anesthesia Drug Market Facts & Figures by Country
3.4.1 North America Veterinary Anesthesia Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Veterinary Anesthesia Drug Sales by Country (2018-2029)
3.4.3 North America Veterinary Anesthesia Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Veterinary Anesthesia Drug Market Facts & Figures by Country
3.5.1 Europe Veterinary Anesthesia Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Veterinary Anesthesia Drug Sales by Country (2018-2029)
3.5.3 Europe Veterinary Anesthesia Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Anesthesia Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Anesthesia Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Veterinary Anesthesia Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Veterinary Anesthesia Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Veterinary Anesthesia Drug Market Facts & Figures by Country
3.7.1 Latin America Veterinary Anesthesia Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Veterinary Anesthesia Drug Sales by Country (2018-2029)
3.7.3 Latin America Veterinary Anesthesia Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Anesthesia Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Anesthesia Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Veterinary Anesthesia Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Veterinary Anesthesia Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Veterinary Anesthesia Drug Sales by Type (2018-2029)
4.1.1 Global Veterinary Anesthesia Drug Sales by Type (2018-2023)
4.1.2 Global Veterinary Anesthesia Drug Sales by Type (2024-2029)
4.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Type (2018-2029)
4.2 Global Veterinary Anesthesia Drug Revenue by Type (2018-2029)
4.2.1 Global Veterinary Anesthesia Drug Revenue by Type (2018-2023)
4.2.2 Global Veterinary Anesthesia Drug Revenue by Type (2024-2029)
4.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Type (2018-2029)
4.3 Global Veterinary Anesthesia Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Veterinary Anesthesia Drug Sales by Application (2018-2029)
5.1.1 Global Veterinary Anesthesia Drug Sales by Application (2018-2023)
5.1.2 Global Veterinary Anesthesia Drug Sales by Application (2024-2029)
5.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Application (2018-2029)
5.2 Global Veterinary Anesthesia Drug Revenue by Application (2018-2029)
5.2.1 Global Veterinary Anesthesia Drug Revenue by Application (2018-2023)
5.2.2 Global Veterinary Anesthesia Drug Revenue by Application (2024-2029)
5.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Application (2018-2029)
5.3 Global Veterinary Anesthesia Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dechra
6.1.1 Dechra Corporation Information
6.1.2 Dechra Description and Business Overview
6.1.3 Dechra Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dechra Veterinary Anesthesia Drug Product Portfolio
6.1.5 Dechra Recent Developments/Updates
6.2 LGC Group
6.2.1 LGC Group Corporation Information
6.2.2 LGC Group Description and Business Overview
6.2.3 LGC Group Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 LGC Group Veterinary Anesthesia Drug Product Portfolio
6.2.5 LGC Group Recent Developments/Updates
6.3 AuroMedics
6.3.1 AuroMedics Corporation Information
6.3.2 AuroMedics Description and Business Overview
6.3.3 AuroMedics Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AuroMedics Veterinary Anesthesia Drug Product Portfolio
6.3.5 AuroMedics Recent Developments/Updates
6.4 Evonik
6.4.1 Evonik Corporation Information
6.4.2 Evonik Description and Business Overview
6.4.3 Evonik Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Evonik Veterinary Anesthesia Drug Product Portfolio
6.4.5 Evonik Recent Developments/Updates
6.5 Gedeon Richter
6.5.1 Gedeon Richter Corporation Information
6.5.2 Gedeon Richter Description and Business Overview
6.5.3 Gedeon Richter Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gedeon Richter Veterinary Anesthesia Drug Product Portfolio
6.5.5 Gedeon Richter Recent Developments/Updates
6.6 Midas Pharma
6.6.1 Midas Pharma Corporation Information
6.6.2 Midas Pharma Description and Business Overview
6.6.3 Midas Pharma Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Midas Pharma Veterinary Anesthesia Drug Product Portfolio
6.6.5 Midas Pharma Recent Developments/Updates
6.7 Fresenius Kabi AG
6.6.1 Fresenius Kabi AG Corporation Information
6.6.2 Fresenius Kabi AG Description and Business Overview
6.6.3 Fresenius Kabi AG Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi AG Veterinary Anesthesia Drug Product Portfolio
6.7.5 Fresenius Kabi AG Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 AstraZeneca Veterinary Anesthesia Drug Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Anesthesia Drug Industry Chain Analysis
7.2 Veterinary Anesthesia Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Anesthesia Drug Production Mode & Process
7.4 Veterinary Anesthesia Drug Sales and Marketing
7.4.1 Veterinary Anesthesia Drug Sales Channels
7.4.2 Veterinary Anesthesia Drug Distributors
7.5 Veterinary Anesthesia Drug Customers
8 Veterinary Anesthesia Drug Market Dynamics
8.1 Veterinary Anesthesia Drug Industry Trends
8.2 Veterinary Anesthesia Drug Market Drivers
8.3 Veterinary Anesthesia Drug Market Challenges
8.4 Veterinary Anesthesia Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
